<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:187px; top:108px; width:369px; height:163px;"><span style="font-family: Arial,Bold; font-size:11px">Edward S. Horton, MD 
<br></span><span style="font-family: Arial; font-size:10px">Edward Horton is Professor of Medicine, Harvard Medical School and 
<br>Senior Investigator at the Joslin Diabetes Center. He received his medical 
<br>degree from Harvard Medical School in 1957. Following internship in 
<br>surgery at Johns Hopkins Hospital and military service in Germany, he 
<br>received residency/fellowship  training in pathology at Dartmouth Medical 
<br>School and in medicine and endocrineology at Duke University Medical 
<br>Center. In 1967, he went to the University of Vermont College of Medicine, 
<br>where he worked for 26 years as Director of Endocrinology and Metabolism 
<br>and then as Chairman of the Department of Medicine. In 1993, he was 
<br>appointed Professor of Medicine at Harvard Medical School and Medical 
<br>Director of the Joslin Diabetes Center. Currently he is a Senior Investigator 
<br>at the Joslin Diabetes Center. He has over 450 publications and is the 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:274px; width:501px; height:377px;"><span style="font-family: Arial; font-size:10px">recipient of several awards, including the ADA Banting Medal for Distinguished Service, the ASCN 
<br>Robert H. Herman Award, the Mizuno Award and Lectureship, the IDF John A. Galloway Award, the 
<br>ADA Outstanding Physician Educator Award, the Endocrine Society Distinguished Physician Award, 
<br>the ADA Albert Renold Award and the JK Lilly Award. He is past president of the American Diabetes 
<br>Association and the American Society for Clinical Nutrition and served as Chairman of the National 
<br></span><span style="font-family: Arial; font-size:10px">Diabetes Advisory Board.</span><span style="font-family: Arial,Bold; font-size:11px"> 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">Lessons Learned from the LookAHEAD Trial 
<br></span><span style="font-family: Arial; font-size:10px">Type 2 diabetes and obesity are increasing rapidly throughout the world. Approaches to the prevention 
<br>and treatment of this dual epidemic have focused on the use of medications and programs of lifestyle 
<br>modification (ILS) that include a healthy diet, weight loss and increased physical activity to improve 
<br>glucose control and other CVD risk factors to reduce the development of long-term complications of 
<br>diabetes.</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:9px"> 
<br></span><span style="font-family: Arial; font-size:10px">The LookAHEAD Trial is comparing the effects of an ILS program with standard care (CON) on CVD 
<br>events and other complications of diabetes in approximately 5000 overweight subjects with 
<br>established type 2 diabetes. After one year of treatment, subjects lost and average of 8% of initial 
<br>body weight and significantly increased their level of physical fitness compared to the CON group. 
<br>They also achieved better glucose control, lower blood pressure and improved lipids. Despite some 
<br>regain in weight, these benefits have been sustained over a period of at least 10 years. However, both 
<br>the control and ILS groups have had relatively low rates of CVD events, with no significant differences 
<br>between the two groups, although there was greater use of antihypertensive and lipid lowering 
<br>medications in the CON group than in the ILS group. The ILS group also had marked improvements in 
<br>obstructive sleep apnea, greater mobility and fewer co-morbidities compared to CON. 
<br></span><span style="font-family: Arial; font-size:9px"> 
<br></span><span style="font-family: Arial; font-size:10px">This study demonstrates that a program of ILS modification can be sustained for a significant period of 
<br></span><span style="font-family: Arial; font-size:10px">time and has long term benefits in reducing several CVD risk factors and improving other co-
<br></span><span style="font-family: Arial; font-size:10px">morbidities.. However, in this study the long-term effects of an ILS program to decrease CVD events 
<br></span><span style="font-family: Arial; font-size:10px">has not been demonstrated. 
<br></span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:252px; top:655px; width:110px; height:10px;"><span style="font-family: Arial,Bold; font-size:10px">Learning objectives: 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:668px; width:492px; height:22px;"><span style="font-family: Arial; font-size:10px">1.  To understand the rationale, design and principal results of the LookAHEAD Trial 
<br>2.  To evaluate the effects of an intensive lifestyle modification program on glycemic control in people 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:693px; width:202px; height:10px;"><span style="font-family: Arial; font-size:10px">with established type 2 diabetes mellitus. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:706px; width:482px; height:10px;"><span style="font-family: Arial; font-size:10px">3.  To evaluate the effects of an intensive lifestyle modification program on cardio-vascular disease 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:718px; width:353px; height:10px;"><span style="font-family: Arial; font-size:10px">risk factors and cardiovascular outcomes in people with type 2 diabetes. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:731px; width:466px; height:10px;"><span style="font-family: Arial; font-size:10px">4.  To evaluate the effects of an intensive lifestyle modification program on other obesity-related 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:744px; width:203px; height:10px;"><span style="font-family: Arial; font-size:10px">conditions in people with type 2 diabetes. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:760px; width:3px; height:7px;"><span style="font-family: ABCDEE+MV Boli; font-size:7px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">40 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:50px; top:651px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:651px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:651px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:651px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:651px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:652px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:652px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:666px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:666px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:678px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:678px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:691px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:691px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:703px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:703px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:716px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:716px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:729px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:729px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:755px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:755px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:755px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:755px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:755px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:741px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:741px; width:0px; height:13px;"></span>
<div style="position:absolute; border: figure 1px solid; writing-mode:False; left:58px; top:108px; width:118px; height:152px;"></div><span style="position:absolute; border: black 1px solid; left:58px; top:108px; width:119px; height:152px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
